Quest Diagnostics (DGX) Raises Quarterly Dividend 15.2% to $0.38; 2.2% Yield

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. APGE
5. USO
6. MU
7. HOOD
8. DFTX
9. GOOGL
10. ABBV

Go back to Quest Diagnostics (DGX) Raises Quarterly Dividend 15.2% to $0.38; 2.2% Yield

Quest Diagnostics (DGX) Tops Q4 EPS by 4c; Guides Above the Street

January 29, 2015 7:18 AM EST

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.85 billion.

Quest Diagnostics sees FY2015 EPS of $4.70-$4.85, versus the consensus of $4.43. Revenues to increase approximately 2% to... More

RedHill Biopharma (RDHL) Completes pre-IND Meeting for RHB-104 Phase III; Offers Progress Update

January 29, 2015 7:14 AM EST

RedHill Biopharma (Nasdaq: RDHL) provided an update on the progress with the ongoing RHB-104 Phase III development program for the treatment of Crohn's disease. The Company, together with Quest Diagnostics (NYSE: DGX), recently concluded a pre-submission meeting with the FDA regarding the development path of a commercial companion diagnostic test for the detection of Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease patients. Following the constructive FDA meeting, RedHill intends to initiate a study of approximately 40 Crohn's disease patients to assess the clinical utility of the companion... More